PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Asthma lawsuits: Glaxo and Serevent & Advair



The May 8 Forbes prints my letter critical of their earlier story on Serevent/Advair litigation. Press coverage of the Forbes story is being criticized for causing undue panic. (Liv Osby, "Advair story causes alarm among some asthma sufferers", Greeneville News, Apr. 7).

 

 


Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute
igorodetski@manhattan-institute.org

Katherine Lazarski
Press Officer,
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.